Biocair Cements its Commitment in Scotland with Edinburgh Facility Expansion

Global specialist in temperature-controlled logistics for life sciences, Biocair, is continuing to grow its UK presence with the expansion of its Edinburgh facility. Now spanning two sites over 5000 sq feet housing operations and administration support, the Scottish facility growth follows an increase in customers and the subsequent demand for specialist shipping for temperature-controlled packaging. 

​​​​​​​

Image Credit: Biocair

There has also been an increase in the requirement for Biocair to support the classification of goods, preparing customs valuations, all levels of shipping paperwork and end to end monitoring. Often supporting SMEs, the specialist team also delivers tailored logistics solutions and complete laboratory moves as protecting samples continues to be paramount.  

The additional demand for these services has driven a growth from a one-person operation when the office opened 10 years ago, to a fully functioning team of 16 today. The specialists operating the unit oversee the logistics process for exporting and importing shipments across the UK and globally, made efficient thanks to Biocair’s proximity to Edinburgh airport.  

Commenting on the expansion, Don Riach, Director of Biocair UK Operations, said: “We began our expansion at the end of last year and this has now been completed after the final installation of equipment and elements such as freezers and racking in a new off-site warehouse. The additional space supports our growing team, which span office personnel to logistics coordinators, and will help us to meet our longer-term growth plans in Scotland. We are now also able to handle and coordinate shipments from new customers in Ireland.” 

The announcement has been made alongside the UK Regenerative Medicine Meeting, which takes place from 8-10 November 2023 in Edinburgh. Biocair will be showcasing its services to cold chain logistics at the event, which supports pharmaceutical, biotechnology and life sciences sectors, as well as presenting the company’s latest industry collaboration with FibroFind, an innovative UK-based Contract Research Organization.

Since the facility in Edinburgh was established, the team has supported some significant projects, including the movements of irreplaceable frozen samples connected to 10 years of research from UK to China, and the shipping of Covid samples at -20.C using temperature-controlled vehicles, seven nights per week for two years.